Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uterine Cervical Neoplasms × sitravatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Lung Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Neoplasms 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Melanoma 1 Lung Diseases 1 Liposarcoma 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Advanced or Metastatic Solid Malignancies 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1 Advanced Malignancies 1 Advanced Biliary Tract Cancer 1 Adenocarcinoma 1

Interventions

Cisplatin 154 Radiotherapy 67 Paclitaxel 63 Brachytherapy 63 Carboplatin 59 pembrolizumab 57 Bevacizumab 36 Gemcitabine 27 Radiation 26 Topotecan 25 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21 Colposcopy 21 Nivolumab 19 human papillomavirus vaccine, L1 type 16, 18 18 Platinum 18 Magnetic Resonance Spectroscopy 18 Papillomavirus Vaccines 17 Drug Therapy 15 Docetaxel 15 Cyclophosphamide 15 Biopsy 15 1,2-diaminocyclohexaneplatinum II citrate 15 Radiotherapy, Intensity-Modulated 14 atezolizumab 13 Taxes 13 Methods 13 Early Intervention, Educational 13 fludarabine 12 Ipilimumab 12 toripalimab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05614453 2023-06-29

ITTACC

Australia New Zealand Gynaecological Oncology Group

Phase 2 Withdrawn

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡